English EN
How quickly do gelatin capsules dissolve or disintegrate?
Beyond Biopharma · Pharmaceutical Gelatin FAQ
Under typical gastric-fluid conditions, a gelatin hard capsule usually disintegrates within 15 to 30 minutes, and often much faster. Gelatin dissolves so readily in warm, aqueous media that the shell is not usually the rate-limiting step for a well designed capsule. Storage in moisture and heat, or contact with aldehyde-releasing fill ingredients, can cause cross-linking that delays dissolution, which is why pharmacopoeia dissolution and disintegration methods often include an enzyme-containing phase intended to distinguish true quality problems from resolvable cross-linking.
Dissolution starts with water and warmth
Gelatin is a water-soluble protein, and capsule shells are essentially a thin, brittle film of dried gelatin with a small amount of water. Two things happen when a capsule reaches the stomach:
- Wetting — the shell is wetted by gastric fluid the moment it is swallowed.
- Hydration and breakup — the film swells as water diffuses in, the seam opens, and the shell fragments dissolve or rupture.
Because gastric fluid is warm (body temperature) and aqueous, dissolution is generally fast. For a compliant, well stored shell the capsule usually ruptures and releases its fill within minutes; pharmacopoeia disintegration tests are written so that a gelatin capsule is expected to disintegrate well within roughly 15 minutes in simulated gastric fluid, though actual times depend on shell quality, method, and media conditions. In practice a well designed capsule releases its contents rapidly enough that some formulators use gelatin capsules precisely to avoid the slow, variable release that can come from a tablet coating.
What the shell is not responsible for
Some release behaviour looks like a shell delay but is really controlled by the formulation of the fill — for example, coated drug particles, matrix-release granules or sustained-release pellets packed inside the shell. In those cases the capsule simply opens quickly and the fill then releases over minutes or hours by design. It is worth checking whether a slow “dissolution” result is the shell at all before suspecting the gelatin.
When dissolution can genuinely slow down
Two well-known conditions make a gelatin shell slower to dissolve, and they are important to a buyer because they affect storage and formulation rather than shell manufacture alone:
| Cause | Why it happens | What it looks like |
|---|---|---|
| Storage moisture and heat | Waterlogged shells become tougher or stickier; heat can gradually age the protein film | Later, slower, variable rupture on storage |
| Cross-linking | Aldehydes from fill ingredients or from oxidation bind together gelatin chains into a tougher, not fully soluble film (a "pellicle") | A thin insoluble membrane forms; dissolution can stall |
Cross-linking is separate from dissolution during initial wetting; it is discussed in more detail in our dedicated cross-linking question.
Why pharmacopoeia methods add enzymes
Dissolution and disintegration methods in the major pharmacopoeias typically include a second medium or phase that contains an enzyme such as pepsin (for acid conditions). The purpose is deliberate and practical: an enzyme-containing medium can digest cross-linked gelatin protein and therefore free the contents, allowing the laboratory to see whether the delay comes from genuine physical cross-linking in the shell or from a real defect in the product. Laboratories also run the test on fresh samples and after accelerated or real-time storage, and compare the two, because a capsule that is fine when manufactured but slows on storage points to cross-linking, while one that fails from day one points to a formulation or manufacturing problem.
Practical summary for formulators and buyers
- Gelatin capsules are essentially fast and reliable disintegrators under normal gastric conditions — count on minutes, not hours.
- Suspect cross-linking or poor storage, not the gelatin itself, when a shell-based delay appears after storage.
- Confirm that your quality team runs the pharmacopoeia method (including the enzyme-containing step) and compares fresh versus stored samples before drawing conclusions.
- Typical functional release is discussed in industry literature; the definitive behaviour for your product should always be confirmed with your own regulatory and quality teams and your suppliers.
